Suven Life Sciences has informed that the Board of Directors of the company, at its meeting held on August 11, 2020, approved the following along with other business matters: took on record and approved the Un-audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter ended 30th June, 2020 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Review Reports of the Statutory Auditors. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from 15th September, 2020 to 17th September, 2020 for taking record of the Members of the Company for the purpose of 31st Annual General Meeting of the Company.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |